Your browser doesn't support javascript.
loading
X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc).
Bergmann, Christina; Hallenberger, Ludwig; Chenguiti Fakhouri, Sara; Merlevede, Benita; Brandt, Amelie; Dees, Clara; Zhu, Honglin; Zehender, Ariella; Zhou, Xiang; Schwab, Annemarie; Chen, Chih-Wei; Györfi, Andrea Hermina; Matei, Alexandru Emil; Chakraborty, Debomita; Trinh-Minh, Thuong; Rauber, Simon; Coras, Roland; Bozec, Aline; Kreuter, Alexander; Ziemer, Mirjana; Schett, Georg; Distler, Jörg H W.
Afiliación
  • Bergmann C; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Bayern, Germany christina.bergmann@uk-erlangen.de.
  • Hallenberger L; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
  • Chenguiti Fakhouri S; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
  • Merlevede B; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
  • Brandt A; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
  • Dees C; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
  • Zhu H; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
  • Zehender A; Department of Rheumatology and Immunology, Xiangya Hospital Central South University, Changsha, China.
  • Zhou X; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
  • Schwab A; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
  • Chen CW; Interdisciplinary Centre for Clinical Research, University Hospital Erlangen, FAU-Erlangen-Nuremberg, Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
  • Györfi AH; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
  • Matei AE; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
  • Chakraborty D; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
  • Trinh-Minh T; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
  • Rauber S; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
  • Coras R; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
  • Bozec A; Department of Neuropathology, Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
  • Kreuter A; Institute for Clinical Immunology University of Erlangen-Nuremberg, Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
  • Ziemer M; Department of Dermatology and Allergology, HELIOS Sankt Elisabeth Klinik Oberhausen, Oberhausen, Nordrhein-Westfalen, Germany.
  • Schett G; Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Leipzig, Leipzig, Sachsen, Germany.
  • Distler JHW; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Bayern, Germany.
Ann Rheum Dis ; 80(8): 1048-1056, 2021 08.
Article en En | MEDLINE | ID: mdl-33903093

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Proteína Inhibidora de la Apoptosis Ligada a X / Beta Catenina Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Ann Rheum Dis Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Proteína Inhibidora de la Apoptosis Ligada a X / Beta Catenina Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Ann Rheum Dis Año: 2021 Tipo del documento: Article País de afiliación: Alemania